{"meta":{"query_hash":"1c0d6ab591e4","filters":{"venue":"Antiviral chemistry & chemotherapy"},"cohort_total":16,"direct_labels_cover":0,"predictions_cover":16,"exported":16,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/1c0d6ab591e4","api":"https://metacan.xera.ac/api/v1/cohort?venue=Antiviral+chemistry+%26+chemotherapy"},"results":[{"id":"W1983656219","doi":"10.1177/095632020601700601","title":"Five Years of Progress on Cyclin-Dependent Kinases and other Cellular Proteins as Potential Targets for Antiviral Drugs","year":2006,"lang":"en","type":"review","venue":"Antiviral chemistry & chemotherapy","topic":"Biochemical and Molecular Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":71,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Cyclin-dependent kinase; Biology; Kinase; Drug discovery; Herpes simplex virus; Virology; Bioinformatics; Cancer; Virus; Cell biology; Cell cycle; Genetics","score_opus":0.011453017587526667,"score_gpt":0.30575447982002973,"score_spread":0.2943014622325031,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1983656219","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0012665349,0.9905607,0.001068706,0.003338917,0.00062106334,0.000011973141,0.00002710711,0.000020917923,0.0030840628],"genre_scores_gemma":[0.007243482,0.98569864,0.0019163595,0.002012326,0.0010904935,0.00002135678,0.000076380114,0.000007701628,0.0019332252],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9994111,0.0001512046,0.00008686793,0.00008338772,0.00017438232,0.000093029805],"domain_scores_gemma":[0.9984622,0.0008761343,0.0001627218,0.00006752234,0.00033099207,0.0001004046],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023797906,0.0007515767,0.0014900458,0.0015075483,0.00057143957,0.0017312041,0.00070028583,0.0018106393,0.0034806347],"category_scores_gemma":[0.0014496744,0.00032743005,0.00068263686,0.0015107221,0.00088738,0.0030354026,0.001065936,0.0028500601,0.0015899045],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005881367,0.00031496183,0.00071688095,0.011054023,0.00012898093,0.00059040927,0.0003831744,0.0007585772,0.017728131,0.020279853,0.026386816,0.92107],"study_design_scores_gemma":[0.000036233185,0.00055338314,0.0010788256,0.0014751606,0.00014322059,0.0010136373,0.00020609843,0.00025540256,0.00851867,0.006162488,0.9805117,0.00004523191],"about_ca_topic_score_codex":0.0006102811,"about_ca_topic_score_gemma":0.0013294624,"teacher_disagreement_score":0.0034806347,"about_ca_system_score_codex":0.0009161444,"about_ca_system_score_gemma":0.0010951719,"threshold_uncertainty_score":0.0125857},"labels":[],"label_agreement":null},{"id":"W1988861859","doi":"10.1177/095632020001100405","title":"Drug Resistance and Drug Combination Features of the Human Immunodeficiency Virus Inhibitor, BCH-10652 [(±)-2′-Deoxy-3′-Oxa-4′-Thiocytidine, dOTC]","year":2000,"lang":"en","type":"article","venue":"Antiviral chemistry & chemotherapy","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BioPhage Pharma (Canada)","funders":"","keywords":"Zidovudine; Zalcitabine; Virology; Lamivudine; Didanosine; Biology; Pharmacology; Chemistry; Virus; Viral disease","score_opus":0.00462799010712656,"score_gpt":0.23209112979432714,"score_spread":0.22746313968720058,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1988861859","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9918759,0.0015245348,0.00068605144,0.000058439076,0.000033437755,0.00006911055,0.00072591164,0.00005561743,0.00497094],"genre_scores_gemma":[0.9960194,0.00048427962,0.0011158707,0.000031835352,0.000012719897,0.00003218452,0.0008830004,0.000009677489,0.0014110602],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99981457,0.000048152255,0.00001586998,0.00003658388,0.000056787838,0.000028163055],"domain_scores_gemma":[0.9998989,0.000023134096,0.000018434315,0.000019911347,0.000013425416,0.000026135134],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010767579,0.0002026095,0.0002620204,0.0001254925,0.000086149055,0.00016852592,0.00015794749,0.0001693912,0.0017241029],"category_scores_gemma":[0.0002743699,0.00008403498,0.00014375536,0.00023284128,0.000114788796,0.00009371336,0.00007352764,0.00030593027,0.0002583949],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011445954,0.0003556863,0.0048961914,0.00007052616,0.000050679926,0.00038873788,0.000030302768,0.0008866631,0.9725218,0.00027827825,0.00047373262,0.01890285],"study_design_scores_gemma":[0.0002614048,0.009291867,0.04120876,0.00001038688,0.00011694493,0.005098491,0.000032496806,0.0040432904,0.92431706,0.000079119236,0.015518447,0.00002176518],"about_ca_topic_score_codex":0.001093032,"about_ca_topic_score_gemma":0.001809596,"teacher_disagreement_score":0.0017241029,"about_ca_system_score_codex":0.00021341657,"about_ca_system_score_gemma":0.00015163705,"threshold_uncertainty_score":0.0057676435},"labels":[],"label_agreement":null},{"id":"W2001744429","doi":"10.1177/095632020401500402","title":"Mutations and Polymorphisms Associated with Antiretroviral Drugs in HIV-1C-Infected African Patients","year":2004,"lang":"en","type":"article","venue":"Antiviral chemistry & chemotherapy","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Fogarty International Center; National Institutes of Health","keywords":"Stavudine; Didanosine; Resistance mutation; Nevirapine; Efavirenz; Zidovudine; Lamivudine; Virology; Reverse transcriptase; Reverse-transcriptase inhibitor; Biology; Viral load; Regimen; Medicine; Internal medicine; Virus; Viral disease; Antiretroviral therapy; Polymerase chain reaction; Genetics; Gene","score_opus":0.0045901976957082825,"score_gpt":0.2143922775556601,"score_spread":0.2098020798599518,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2001744429","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99935836,0.00020845621,0.000023484961,0.000028302185,0.0000023854966,0.000007921086,0.000055983528,0.0000015846915,0.00031360565],"genre_scores_gemma":[0.99956256,0.00011043863,0.000097009506,0.000035960744,0.0000048807105,0.00000924731,0.00007655714,0.0000011294542,0.000102087724],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99977285,0.00005637279,0.000027069846,0.000046411344,0.00003801167,0.000059361075],"domain_scores_gemma":[0.99963,0.0000939834,0.00012522272,0.000016990745,0.00004267483,0.00009107263],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018185783,0.00022820884,0.00022637977,0.0010411583,0.0007230376,0.00043614663,0.00013767183,0.000472673,0.0016694854],"category_scores_gemma":[0.0012969034,0.00019032747,0.00015609141,0.0011181638,0.00025681,0.0002476906,0.0001714069,0.0003499253,0.00015018656],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045438862,0.000106117914,0.9852529,0.000024697061,0.000030586973,0.0013862645,0.0003457588,0.00007393008,0.006101818,0.00007409849,0.00013207922,0.006017229],"study_design_scores_gemma":[0.000040283543,0.00030190655,0.9935819,0.000024014702,0.000025182942,0.0041253376,0.00042337607,0.00025626947,0.0006229156,0.00006299325,0.00052691816,0.000008904663],"about_ca_topic_score_codex":0.0038664183,"about_ca_topic_score_gemma":0.0045644236,"teacher_disagreement_score":0.0038664183,"about_ca_system_score_codex":0.00035278435,"about_ca_system_score_gemma":0.00025720376,"threshold_uncertainty_score":0.007687807},"labels":[],"label_agreement":null},{"id":"W2014399345","doi":"10.1177/095632020701800201","title":"Apricitabine: A Novel Deoxycytidine Analogue Nucleoside Reverse Transcriptase Inhibitor for the Treatment of Nucleoside-Resistant HIV Infection","year":2007,"lang":"en","type":"review","venue":"Antiviral chemistry & chemotherapy","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Boehringer Ingelheim (Canada); McGill University; Jewish General Hospital","funders":"","keywords":"Reverse-transcriptase inhibitor; Pharmacology; Nucleoside Reverse Transcriptase Inhibitor; Emtricitabine; Nucleoside analogue; Nucleoside; Reverse transcriptase; Lamivudine; Deoxycytidine kinase; Didanosine; Resistance mutation; Zalcitabine; Biology; Virology; Deoxycytidine; Chemotherapy; Virus; Biochemistry; RNA","score_opus":0.04955322289353962,"score_gpt":0.3322231562892709,"score_spread":0.28266993339573127,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2014399345","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7704605,0.18772574,0.007777364,0.0017066648,0.0013431128,0.0023832608,0.002398238,0.001551585,0.024653453],"genre_scores_gemma":[0.9170263,0.056439556,0.006895251,0.0011519896,0.0005091347,0.00063907873,0.0029501282,0.000052483792,0.014336051],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9999039,0.000022182256,0.000009188728,0.000022738634,0.000022709462,0.00001915574],"domain_scores_gemma":[0.999933,0.000009267603,0.0000137798,0.000006120834,0.000009563374,0.00002820631],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002538653,0.0005298364,0.0005567624,0.00034728769,0.00016765275,0.0003273486,0.00050024356,0.0005883115,0.0029514774],"category_scores_gemma":[0.00016121958,0.0001247636,0.00032218237,0.00027694413,0.00018468327,0.00022102744,0.00019321262,0.0009797231,0.00081846805],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.026062459,0.004885693,0.0021161034,0.0024890364,0.00034647642,0.0017130551,0.00014042301,0.0013682685,0.27753007,0.0008247368,0.01327486,0.6692488],"study_design_scores_gemma":[0.13089861,0.14903507,0.0445186,0.00053557096,0.0012981364,0.034529123,0.00011952368,0.004383346,0.24273983,0.00070916984,0.3910465,0.00018658824],"about_ca_topic_score_codex":0.0006121735,"about_ca_topic_score_gemma":0.0014072607,"teacher_disagreement_score":0.0029514774,"about_ca_system_score_codex":0.0002789063,"about_ca_system_score_gemma":0.00030086437,"threshold_uncertainty_score":0.009873688},"labels":[],"label_agreement":null},{"id":"W2021855902","doi":"10.1177/095632020501600502","title":"<i>In Vitro</i> Activity of SPD754, a New Deoxycytidine Nucleoside Reverse Transcriptase Inhibitor (NRTI), against 215 HIV-1 Isolates Resistant to Other NRTIs","year":2005,"lang":"en","type":"article","venue":"Antiviral chemistry & chemotherapy","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Boehringer Ingelheim (Canada)","funders":"","keywords":"Didanosine; Abacavir; Zidovudine; Nucleoside Reverse Transcriptase Inhibitor; Lamivudine; Reverse transcriptase; Virology; Reverse-transcriptase inhibitor; Stavudine; Deoxycytidine; Zalcitabine; Deoxycytidine kinase; Resistance mutation; Biology; Human immunodeficiency virus (HIV); Virus; Viral load; Sida; Chemotherapy; Polymerase chain reaction; Viral disease; Biochemistry; Gemcitabine; Antiretroviral therapy","score_opus":0.008584953640573333,"score_gpt":0.24390346410491645,"score_spread":0.23531851046434313,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2021855902","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974739,0.0006247992,0.00030352792,0.000017825398,0.000008221078,0.000029473093,0.0008442262,0.000011865819,0.00068619725],"genre_scores_gemma":[0.99357504,0.0006329716,0.00206293,0.000037575857,0.00001760302,0.000032252592,0.002938516,0.000007523569,0.0006956448],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9996406,0.00008312354,0.00004911511,0.00006723517,0.000102968006,0.00005693639],"domain_scores_gemma":[0.9997801,0.00006086318,0.00004474287,0.000029044353,0.00004951564,0.00003580054],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019955703,0.0003951438,0.00031726217,0.0003178798,0.000153797,0.00031738685,0.00021385023,0.00020466451,0.0005895085],"category_scores_gemma":[0.0003428709,0.00012316053,0.00032642708,0.00042346452,0.00018250282,0.00013034191,0.0001625878,0.00023547548,0.00019754746],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006054555,0.00017008255,0.0074226786,0.00009667721,0.000039864295,0.00010172028,0.00006722204,0.00069469196,0.98459435,0.000043291435,0.0001318918,0.0060320836],"study_design_scores_gemma":[0.000036984744,0.0055439784,0.05572896,0.000013455855,0.00010247815,0.0007760598,0.00008618422,0.0013565569,0.93380433,0.000028103337,0.0025071222,0.000015825399],"about_ca_topic_score_codex":0.0032924286,"about_ca_topic_score_gemma":0.003405008,"teacher_disagreement_score":0.0032924286,"about_ca_system_score_codex":0.00022809135,"about_ca_system_score_gemma":0.00019958483,"threshold_uncertainty_score":0.006546557},"labels":[],"label_agreement":null},{"id":"W2036804791","doi":"10.1177/095632020501600305","title":"Inhibition of Hepatitis B Virus Gene Expression and Replication by Helioxanthin and its Derivative","year":2005,"lang":"en","type":"article","venue":"Antiviral chemistry & chemotherapy","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Hepatitis B virus; Nucleoside; Virology; Lamivudine; Biology; Nucleoside analogue; DNA; Virus; Molecular biology; Biochemistry","score_opus":0.011913783096706576,"score_gpt":0.2687079380968992,"score_spread":0.2567941550001926,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2036804791","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9830761,0.011051903,0.0029586593,0.00008577853,0.000041236464,0.000041769526,0.00016776708,0.00006983108,0.002506945],"genre_scores_gemma":[0.989638,0.0042836773,0.0026381584,0.00008272432,0.000026593758,0.00004493883,0.00035712274,0.0000129452965,0.0029159896],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999542,0.000010242096,0.0000053596796,0.0000072753924,0.0000135512455,0.000009244213],"domain_scores_gemma":[0.9999635,0.0000070985793,0.000014156227,0.000004238581,0.000003710842,0.0000072823186],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007957164,0.0002855525,0.00012157434,0.00017508656,0.00006947763,0.00014726204,0.00016482481,0.00017204072,0.0009659735],"category_scores_gemma":[0.000086646185,0.0000892155,0.00017413458,0.000087992754,0.0001284562,0.00019022025,0.00016704925,0.00027791673,0.0002024672],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007632596,0.000030542862,0.000094843184,0.00005216164,0.000006184847,0.000064652086,0.0000073587375,0.00006437136,0.99608046,0.000060987615,0.000018539109,0.0034434958],"study_design_scores_gemma":[0.00006248396,0.0023099124,0.0041334783,0.000013316232,0.000029438728,0.000707495,0.000021127418,0.000527708,0.9866371,0.0000820148,0.0054660845,0.000009889972],"about_ca_topic_score_codex":0.00008499945,"about_ca_topic_score_gemma":0.00014745482,"teacher_disagreement_score":0.0009659735,"about_ca_system_score_codex":0.00006023576,"about_ca_system_score_gemma":0.00006815769,"threshold_uncertainty_score":0.0032315254},"labels":[],"label_agreement":null},{"id":"W2049579004","doi":"10.3851/imp1443","title":"Factors Affecting Template Usage in the Development of K65R Resistance in Subtype C Variants of HIV Type-1","year":2009,"lang":"en","type":"article","venue":"Antiviral chemistry & chemotherapy","topic":"HIV Research and Treatment","field":"Immunology and Microbiology","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"Canadian Institutes of Health Research","keywords":"Biology; Reverse transcriptase; Template; DNA; Nucleotide; Molecular biology; Genetics; RNA; Mutation; Gene","score_opus":0.02272376542692057,"score_gpt":0.28006712304370757,"score_spread":0.257343357616787,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2049579004","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997177,0.0009213358,0.0007356568,0.000030569077,0.000009968472,0.00003574368,0.0001659232,0.00003413898,0.00088967377],"genre_scores_gemma":[0.9982168,0.00026223893,0.00077691645,0.00003928154,0.000008821095,0.000016452168,0.00023330709,0.00002655211,0.0004195709],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9996182,0.00009063461,0.00003740989,0.00006482623,0.00011880803,0.000070135786],"domain_scores_gemma":[0.99931717,0.00020276417,0.00023250753,0.000052173917,0.00007246215,0.00012288174],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039755632,0.00027925405,0.00022684688,0.00023083399,0.00016760702,0.0006392426,0.0002583801,0.00044641836,0.0018433568],"category_scores_gemma":[0.00088549056,0.00019242152,0.00022845613,0.00017282351,0.00019524028,0.00018210059,0.00013837437,0.0003836634,0.0007326025],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005031852,0.00009786208,0.0077924374,0.000059842605,0.000018978904,0.00021300219,0.000061077386,0.00017547487,0.9867866,0.000091114984,0.00008148434,0.004118853],"study_design_scores_gemma":[0.00004028732,0.0015882278,0.13066117,0.00003183259,0.00009431514,0.0019045589,0.00020241583,0.0021772692,0.8604561,0.00013305273,0.0026746653,0.000036127854],"about_ca_topic_score_codex":0.0015590272,"about_ca_topic_score_gemma":0.0013045985,"teacher_disagreement_score":0.0018433568,"about_ca_system_score_codex":0.00031231495,"about_ca_system_score_gemma":0.00040715063,"threshold_uncertainty_score":0.006166637},"labels":[],"label_agreement":null},{"id":"W2077627087","doi":"10.1177/095632020401500504","title":"Variability in the PR and RT Genes of HIV-1 Isolated from Recently Infected Subjects","year":2004,"lang":"en","type":"review","venue":"Antiviral chemistry & chemotherapy","topic":"HIV Research and Treatment","field":"Immunology and Microbiology","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; McGill University; Jewish General Hospital","funders":"Canadian Institutes of Health Research; Health Canada; Canadian Foundation for AIDS Research; American Physicians Fellowship for Medicine in Israel; amfAR, The Foundation for AIDS Research","keywords":"Biology; Gene; Reverse transcriptase; Virology; Nucleotide; Protease; Lentivirus; Viral disease; Drug resistance; Virus; Sida; Genetics; Human immunodeficiency virus (HIV); Polymerase chain reaction; Enzyme","score_opus":0.017031320762275138,"score_gpt":0.28716780797670216,"score_spread":0.270136487214427,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2077627087","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0006812627,0.99834347,0.00014659156,0.0001346193,0.00008948536,0.00000312147,0.000010995792,0.000005878544,0.0005845229],"genre_scores_gemma":[0.0044395565,0.9940387,0.00036896922,0.0001448841,0.00016943902,0.000010432491,0.000046913072,0.0000020852547,0.0007790862],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9996439,0.000047746104,0.00005501636,0.00011423271,0.00011717776,0.00002190003],"domain_scores_gemma":[0.9995647,0.00017707155,0.000087340675,0.000016425969,0.00012439709,0.00003001987],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008995621,0.0007553646,0.0014697438,0.0015787662,0.00018716104,0.00082346686,0.00073342223,0.0009122855,0.0010392783],"category_scores_gemma":[0.0007674141,0.00028755507,0.00021832385,0.001514813,0.00062705,0.0009712,0.00027000098,0.0008385014,0.0013709388],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000121993435,0.000033034186,0.0010650605,0.004582035,0.000046822945,0.00023275983,0.000064584114,0.00019202734,0.0031177409,0.0006406258,0.004401752,0.9855016],"study_design_scores_gemma":[0.0000705376,0.000839927,0.020755852,0.0019195267,0.00024310571,0.011928131,0.00020330267,0.00022159782,0.0056834174,0.0018394606,0.9562361,0.000059136357],"about_ca_topic_score_codex":0.0008651105,"about_ca_topic_score_gemma":0.0011835165,"teacher_disagreement_score":0.0015787662,"about_ca_system_score_codex":0.00052857585,"about_ca_system_score_gemma":0.0005585545,"threshold_uncertainty_score":0.0047574043},"labels":[],"label_agreement":null},{"id":"W2109240928","doi":"10.1177/2040206614566580","title":"Identification of a dibenzocyclooctadiene lignan as a HIV-1 non-nucleoside reverse transcriptase inhibitor","year":2015,"lang":"en","type":"article","venue":"Antiviral chemistry & chemotherapy","topic":"Plant-derived Lignans Synthesis and Bioactivity","field":"Biochemistry, Genetics and Molecular Biology","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"Canadian Institutes of Health Research","keywords":"Lignan; Reverse transcriptase; Reverse-transcriptase inhibitor; Nucleoside Reverse Transcriptase Inhibitor; Enzyme; Human immunodeficiency virus (HIV); Biology; Nucleoside; Mechanism of action; In vitro; EC50; Drug; Virology; Pharmacology; Chemistry; Biochemistry; Stereochemistry; Viral disease; Antiretroviral therapy; Sida; Viral load; RNA","score_opus":0.00906468489302717,"score_gpt":0.23144586016513236,"score_spread":0.22238117527210519,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2109240928","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97539586,0.004857182,0.01047693,0.000298522,0.000039530718,0.00014481359,0.0007252,0.000064360676,0.007997573],"genre_scores_gemma":[0.9796284,0.0028149674,0.010061683,0.00014753835,0.0000183669,0.000028650262,0.0011924553,0.0000108973145,0.0060969777],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99996984,0.000004182979,0.000001529941,0.0000063053308,0.000010260089,0.000007865242],"domain_scores_gemma":[0.99996483,0.000004622841,0.0000060116145,0.0000034858451,0.000009334513,0.000011801575],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010099925,0.00024050502,0.00016455974,0.00024639748,0.00009512765,0.000258304,0.00017928796,0.0002028817,0.0016356729],"category_scores_gemma":[0.00006601745,0.000070598864,0.00016992488,0.00020365286,0.00012466703,0.00016905366,0.00012244447,0.00026483534,0.0003837113],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007670007,0.00006945053,0.0002723601,0.00006763435,0.000006159184,0.00014049758,0.000014350363,0.00035032482,0.9927689,0.00033049806,0.00006338758,0.005839794],"study_design_scores_gemma":[0.000054490512,0.0012549048,0.0049611507,0.000026145879,0.000034553235,0.0006014696,0.000039133116,0.0018246833,0.9779489,0.0003382946,0.012903631,0.000012779737],"about_ca_topic_score_codex":0.00042803053,"about_ca_topic_score_gemma":0.001157419,"teacher_disagreement_score":0.0016356729,"about_ca_system_score_codex":0.00025929912,"about_ca_system_score_gemma":0.00029445137,"threshold_uncertainty_score":0.005471885},"labels":[],"label_agreement":null},{"id":"W2313954337","doi":"10.1177/095632020401500401","title":"Potential of 4′-C-Substituted Nucleosides for the Treatment of HIV-1","year":2004,"lang":"en","type":"review","venue":"Antiviral chemistry & chemotherapy","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Ottawa Hospital Research Institute","keywords":"Human immunodeficiency virus (HIV); Stereochemistry; Chemistry; Pharmacology; Virology; Medicine","score_opus":0.023442323400439172,"score_gpt":0.310387022912384,"score_spread":0.28694469951194485,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2313954337","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0024499956,0.99231225,0.00058792793,0.0001249083,0.000108862,0.0000124876315,0.000020907146,0.000010998478,0.0043715937],"genre_scores_gemma":[0.008978442,0.98743105,0.0012213744,0.00013807934,0.00006861862,0.000018649529,0.00004398285,0.0000019373854,0.0020979815],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9999285,0.000015787447,0.0000069331963,0.000012423266,0.00002708129,0.000009310277],"domain_scores_gemma":[0.9999666,0.000012553499,0.000006929356,0.0000016009725,0.000008066199,0.000004171246],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020443868,0.0005512068,0.0005454248,0.0008577013,0.00018055593,0.00028195154,0.00037602085,0.0005217328,0.0019135989],"category_scores_gemma":[0.000118984884,0.00016515833,0.00024670095,0.0006803316,0.00017889742,0.0004418462,0.00023319053,0.0005097533,0.001260134],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015470192,0.00015908976,0.0002457258,0.010891389,0.00006942651,0.0006795281,0.00012391245,0.001455528,0.06117035,0.0072844033,0.0058996268,0.91186625],"study_design_scores_gemma":[0.000047842455,0.00044951693,0.0009850034,0.0009819061,0.00007427184,0.0025394983,0.000056718876,0.00030871845,0.022849824,0.0018274513,0.96985596,0.00002322124],"about_ca_topic_score_codex":0.00060398906,"about_ca_topic_score_gemma":0.0012666502,"teacher_disagreement_score":0.0019135989,"about_ca_system_score_codex":0.00030887354,"about_ca_system_score_gemma":0.00038900078,"threshold_uncertainty_score":0.006401658},"labels":[],"label_agreement":null},{"id":"W2323588417","doi":"10.1177/095632020001100602","title":"Selection of Resistance-Conferring Mutations in HIV-1 by the Nucleoside Reverse Transcriptase Inhibitors (+/-)dOTC and (+/-)dOTFC","year":2000,"lang":"en","type":"article","venue":"Antiviral chemistry & chemotherapy","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; BioPhage Pharma (Canada); Jewish General Hospital","funders":"Medical Research Council Canada","keywords":"Reverse transcriptase; Resistance mutation; Biology; Mutation; Nucleoside; Virology; Nucleotidyltransferase; Virus; Genotype; Molecular biology; Genetics; RNA; Gene","score_opus":0.00566320649577984,"score_gpt":0.22530737920162283,"score_spread":0.219644172705843,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2323588417","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983235,0.00035620783,0.0004850202,0.000013988191,0.0000043793757,0.000024434654,0.0002663897,0.000027104275,0.0004989456],"genre_scores_gemma":[0.9957004,0.00036906407,0.0023556491,0.000021767231,0.000005510388,0.000026592714,0.0006451178,0.00002810342,0.00084787485],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997241,0.000059508435,0.000030901203,0.00006515895,0.000079689504,0.000040676467],"domain_scores_gemma":[0.999838,0.000040714323,0.000050857103,0.000024968998,0.00002270316,0.000022803128],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016428037,0.00025288042,0.00032074412,0.00018342708,0.00011577563,0.00029114872,0.0001809118,0.00020883609,0.0006751482],"category_scores_gemma":[0.00030245708,0.00015232629,0.00016752188,0.00017938013,0.00011283105,0.000091635535,0.000113863796,0.0002398126,0.00019789793],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010295986,0.00003080259,0.0004966966,0.000013361565,0.000007561274,0.000051643943,0.000013608657,0.000089003435,0.9972421,0.000022357488,0.000025107876,0.0019047277],"study_design_scores_gemma":[0.00001907644,0.0005599664,0.010049569,0.000003850489,0.00002496096,0.0008315117,0.000018092172,0.0009658573,0.9866371,0.000009835287,0.00087311585,0.000007119323],"about_ca_topic_score_codex":0.0012063185,"about_ca_topic_score_gemma":0.0018371056,"teacher_disagreement_score":0.0012063185,"about_ca_system_score_codex":0.00025443206,"about_ca_system_score_gemma":0.00015073505,"threshold_uncertainty_score":0.00239861},"labels":[],"label_agreement":null},{"id":"W2326074019","doi":"10.1177/095632020401500302","title":"Clinical Utility of Current NNRTIs and Perspectives of New Agents in This Class under Development","year":2004,"lang":"en","type":"review","venue":"Antiviral chemistry & chemotherapy","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Valeant Pharmaceuticals International; Bristol-Myers Squibb; Boehringer Ingelheim","keywords":"Nucleoside Reverse Transcriptase Inhibitor; Reverse transcriptase; Dosing; Protease inhibitor (pharmacology); Virology; Reverse-transcriptase inhibitor; Pharmacology; Human immunodeficiency virus (HIV); ANTIRETROVIRAL AGENTS; Medicine; Biology; Antiretroviral therapy; Viral load; Genetics; RNA","score_opus":0.12437243587991338,"score_gpt":0.4137304869345004,"score_spread":0.289358051054587,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2326074019","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00017867521,0.9977901,0.00012975525,0.00027093038,0.00011878477,0.0000043690907,0.000010535761,0.0000040655873,0.0014927222],"genre_scores_gemma":[0.0012413391,0.99685186,0.00041038272,0.00022966093,0.00020840747,0.000008825811,0.00002618083,0.0000015972175,0.0010218304],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9994331,0.000113429574,0.000073630756,0.00008630601,0.00025371826,0.00003972093],"domain_scores_gemma":[0.9994221,0.0002105392,0.0001017806,0.000026905182,0.00018994673,0.00004889297],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016029418,0.00094000343,0.0016656765,0.0021230853,0.000344586,0.0013243417,0.0010805066,0.0015375225,0.004596867],"category_scores_gemma":[0.0011086087,0.0003095138,0.00060963165,0.0018764373,0.0005591611,0.0018324117,0.0004811124,0.0016168347,0.003150593],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001401861,0.00008775844,0.00030441792,0.009101871,0.00007043879,0.0003959895,0.00007742579,0.00041072207,0.0037946512,0.004025236,0.010496566,0.97109467],"study_design_scores_gemma":[0.00004810744,0.00026930668,0.001153752,0.0027796896,0.000106615866,0.0025363052,0.00009416968,0.00014626459,0.0012107682,0.0027653337,0.98887026,0.000019540146],"about_ca_topic_score_codex":0.0008641964,"about_ca_topic_score_gemma":0.0019388018,"teacher_disagreement_score":0.004596867,"about_ca_system_score_codex":0.00066075375,"about_ca_system_score_gemma":0.0011957951,"threshold_uncertainty_score":0.015377998},"labels":[],"label_agreement":null},{"id":"W2329003397","doi":"10.1177/095632020701800205","title":"Kinetics of Inhibition of HIV Type 1 Reverse Transcriptase-Bearing NRTI-associated Mutations by Apricitabine Triphosphate","year":2007,"lang":"en","type":"article","venue":"Antiviral chemistry & chemotherapy","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"Canadian Institutes of Health Research","keywords":"Reverse transcriptase; Resistance mutation; Biology; Primer (cosmetics); Nucleotidyltransferase; Reverse-transcriptase inhibitor; Mutation; Molecular biology; Virology; Nucleoside Reverse Transcriptase Inhibitor; Wild type; Nucleoside; Mutant; Chemistry; RNA; Genetics; Gene","score_opus":0.009658679323601324,"score_gpt":0.24775137503491812,"score_spread":0.2380926957113168,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2329003397","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99120694,0.0027539704,0.00403872,0.000024659867,0.000014260335,0.00004494891,0.00036815403,0.00008448402,0.0014639304],"genre_scores_gemma":[0.99324715,0.0009755469,0.0026734064,0.000022945269,0.0000075617277,0.00004452364,0.0007823273,0.000039806353,0.0022067176],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997117,0.00007160209,0.000027741453,0.00005248482,0.00007690872,0.000059524384],"domain_scores_gemma":[0.99921453,0.00039249114,0.0001175029,0.00006838436,0.00015126196,0.000055836208],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045073387,0.0003512055,0.00044625305,0.00015592139,0.000089834604,0.00040279937,0.0003368359,0.0002460233,0.0012626551],"category_scores_gemma":[0.0009489277,0.0002337829,0.00023756552,0.00018291867,0.00016688622,0.00034546177,0.00011938926,0.0005297367,0.00059852813],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007956896,0.000083005514,0.00094567373,0.00009367569,0.000020663303,0.00004815816,0.00008143856,0.0014225049,0.989962,0.00021933058,0.00006376095,0.006264163],"study_design_scores_gemma":[0.000017875516,0.0010047196,0.0026577604,0.000007284028,0.000018132996,0.00010635351,0.000021959138,0.0042534857,0.9908835,0.000054615626,0.000963973,0.000010237241],"about_ca_topic_score_codex":0.00093111995,"about_ca_topic_score_gemma":0.00073196396,"teacher_disagreement_score":0.0012626551,"about_ca_system_score_codex":0.00040303005,"about_ca_system_score_gemma":0.00022346515,"threshold_uncertainty_score":0.004224062},"labels":[],"label_agreement":null},{"id":"W2792985786","doi":"10.1177/2040206618762985","title":"Frequent cross-resistance to rilpivirine among subtype C HIV-1 from first-line antiretroviral therapy failures in South Africa","year":2018,"lang":"en","type":"article","venue":"Antiviral chemistry & chemotherapy","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"AIDS Vancouver","funders":"Bill and Melinda Gates Foundation","keywords":"Rilpivirine; Efavirenz; Virology; Reverse transcriptase; Reverse-transcriptase inhibitor; Nevirapine; Drug resistance; Nucleoside Reverse Transcriptase Inhibitor; Medicine; Resistance mutation; Human immunodeficiency virus (HIV); Viral load; Antiretroviral therapy; Biology; Polymerase chain reaction; Genetics","score_opus":0.013935754908560982,"score_gpt":0.262476883679566,"score_spread":0.24854112877100504,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2792985786","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99966836,0.00009418323,0.00003177637,0.000017766819,9.880226e-7,0.000012085072,0.000044129454,0.0000014166476,0.0001293209],"genre_scores_gemma":[0.9997149,0.000074299365,0.000056658733,0.000022747,0.0000018698961,0.000007159388,0.000048164587,0.0000010723091,0.00007309034],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99973816,0.000053716536,0.000020299329,0.00006558567,0.000039264265,0.000083022074],"domain_scores_gemma":[0.9996215,0.00008733357,0.00014812071,0.000024012976,0.000056669112,0.000062311774],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003078678,0.00037568668,0.00029536462,0.0008747502,0.00081092573,0.0005056315,0.00024522308,0.00035463288,0.0016151144],"category_scores_gemma":[0.0011254391,0.00018640359,0.00014354251,0.0005637019,0.00049567106,0.00030327684,0.00034504704,0.00024586407,0.00013850677],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023809639,0.00006657679,0.9666528,0.000088859466,0.00003805544,0.0019454715,0.0040758555,0.000059009646,0.01708641,0.000041698306,0.00019922633,0.009507979],"study_design_scores_gemma":[0.000021470247,0.00026862533,0.99103945,0.000029182691,0.00003150037,0.0037984187,0.002427044,0.00012659348,0.0015785396,0.000030491925,0.00063838466,0.000010156276],"about_ca_topic_score_codex":0.014598389,"about_ca_topic_score_gemma":0.016421052,"teacher_disagreement_score":0.014598389,"about_ca_system_score_codex":0.00049994874,"about_ca_system_score_gemma":0.00032248016,"threshold_uncertainty_score":0.029026866},"labels":[],"label_agreement":null},{"id":"W4210891386","doi":"10.1177/095632020701800601","title":"Montreal Welcomes 21st ICAR","year":2007,"lang":"en","type":"article","venue":"Antiviral chemistry & chemotherapy","topic":"Clinical practice guidelines implementation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pharmacognosy; Biology; Biological activity; In vitro; Genetics","score_opus":0.06288153535063165,"score_gpt":0.4141452727979068,"score_spread":0.3512637374472751,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4210891386","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0024269146,0.008379433,0.0012410837,0.18141367,0.16358857,0.0005494745,0.004402492,0.0020056034,0.6359927],"genre_scores_gemma":[0.0023542207,0.0005777048,0.00036620395,0.007495195,0.002943246,0.000040225794,0.00045552553,0.0001417303,0.9856258],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99636024,0.00041611542,0.00007380138,0.00033386567,0.0017269988,0.0010889963],"domain_scores_gemma":[0.9932626,0.00043912104,0.00018316411,0.00031573037,0.0024987992,0.003300561],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0039241225,0.0013939152,0.0012618209,0.0020026069,0.0049507567,0.008833471,0.002467604,0.010376619,0.42677528],"category_scores_gemma":[0.0063669393,0.0006994831,0.001739987,0.0010177667,0.0012339666,0.0012252885,0.0037342845,0.006056118,0.121105336],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000045512883,0.000023897894,0.00013905112,0.000024792193,0.0000053076324,0.0001247772,0.000012986011,0.00003463488,0.00007619277,0.0011317541,0.9888698,0.009511364],"study_design_scores_gemma":[0.000017001608,0.000013386448,0.0006693055,0.000018225857,0.000003049212,0.000017368297,0.000039137856,0.000042810247,0.000041812687,0.00014103064,0.99898964,0.000007232605],"about_ca_topic_score_codex":0.20549971,"about_ca_topic_score_gemma":0.55824447,"teacher_disagreement_score":0.7945003,"about_ca_system_score_codex":0.010067071,"about_ca_system_score_gemma":0.022207865,"threshold_uncertainty_score":0.8176355},"labels":[],"label_agreement":null},{"id":"W4318460047","doi":"10.1177/20402066231152971","title":"The development of BVDU: An odyssey","year":2023,"lang":"en","type":"review","venue":"Antiviral chemistry & chemotherapy","topic":"Herpesvirus Infections and Treatments","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Varicella zoster virus; Nucleoside analogue; Famciclovir; Thymidine kinase; Herpes simplex virus; Deoxyuridine; Valaciclovir; Virology; Penciclovir; Biology; Virus; Herpesviridae; Nucleoside; Biochemistry; DNA; Viral disease","score_opus":0.07637125898134986,"score_gpt":0.39785224728950075,"score_spread":0.32148098830815086,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4318460047","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.045967624,0.577488,0.11264027,0.020051721,0.017054014,0.00045245787,0.0015327838,0.0034407363,0.22137244],"genre_scores_gemma":[0.20121317,0.30137557,0.094211824,0.012094044,0.003104106,0.00053392805,0.0021032428,0.0009853542,0.38437876],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99956745,0.00006364164,0.00002436651,0.0000995864,0.00019368489,0.000051331666],"domain_scores_gemma":[0.9997054,0.000034649063,0.000040674968,0.000027058779,0.000098049255,0.00009419517],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009070586,0.00067840185,0.0003834705,0.000651778,0.00054550305,0.0014772966,0.00096401566,0.0011243541,0.011611155],"category_scores_gemma":[0.0007396473,0.0003070977,0.00045504994,0.00054579426,0.00072226865,0.0015126242,0.001289087,0.0018510972,0.008523069],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006955405,0.00023128843,0.0005938837,0.001718948,0.000049373517,0.00046828607,0.0004553573,0.00043539578,0.17499329,0.043098994,0.060776986,0.7164826],"study_design_scores_gemma":[0.000040212544,0.00036274843,0.00027532963,0.000077750694,0.00001744104,0.00065111317,0.000055300003,0.00030233417,0.03998834,0.0014877508,0.95672405,0.000017710207],"about_ca_topic_score_codex":0.0012373633,"about_ca_topic_score_gemma":0.0012166168,"teacher_disagreement_score":0.011611155,"about_ca_system_score_codex":0.0007053108,"about_ca_system_score_gemma":0.00077733933,"threshold_uncertainty_score":0.038843215},"labels":[],"label_agreement":null}]}